Table 4. Safety summary.
AEs | Any grade, n (%) | Grade 3, n (%) |
---|---|---|
Fatigue | 6 (66.7) | 1 (11.1) |
Hypertension | 5 (55.6) | 2 (22.2) |
ALT or AST elevation | 6 (66.7) | 0 (0.0) |
Hypothyroidism | 1 (11.1) | 0 (0.0) |
Decreased appetite | 5 (55.6) | 1 (11.1) |
Abdominal pain | 1 (11.1) | 0 (0.0) |
Vomiting | 2 (22.2) | 0 (0.0) |
Skin rash | 3 (33.3) | 1 (11.1) |
Anaemia | 1 (11.1) | 0 (0.0) |
Diarrhoea | 1 (11.1) | 0 (0.0) |
Hand-foot syndrome | 2 (22.2) | 0 (0.0) |
Leukocytopenia | 2 (22.2) | 1 (11.1) |
Nasal haemorrhage | 4 (44.4) | 1 (11.1) |
Asthma | 1 (11.1) | 1 (11.1) |
AEs, adverse events; ALT, alanine aminotransferase; AST, aspartate aminotransferase.